Maxcord Pharmaceuticals Private Limited
About Maxcord Pharmaceuticals Private Limited
Data last updated:
Maxcord Pharmaceuticals Private Limited is a private limited company based in Delhi, India. It operates in the paper and paper products segment of the paper and packaging sector. It was incorporated on 15 September 2023.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U21002DL2023PTC420088.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Dhruv Bhatia and Suresh Kumar Bhatia.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at S N – 1705 G/F, Bhagirath Palace, Delhi, India – 110006.
Company details
Contact details
Maxcord Pharmaceuticals Private Limited's registered office is in Delhi, Delhi.
- Registered AddressS N – 1705 G/F, Bhagirath Palace, Delhi, India – 110006
- IndustryPaper, Paper & Paper Products, Manufacturing
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Maxcord Pharmaceuticals Private Limited
FY 2025 filings availableFinancial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ||
| Other Income | ||
| Total Revenue | ||
| Cost of Materials Consumed | ||
| Employee Benefit Expense | ||
| Finance Costs | ||
| Depreciation and Amortisation | ||
| Other Expenses | ||
| Total Expenses | ||
| EBITDA | ||
| Profit Before Tax | ||
| Tax Expense | ||
| Net Profit (PAT) | ||
| Balance Sheet | ||
| Share Capital | ||
| Reserves and Surplus | ||
| Net Worth (Total Equity) | ||
| Long-term Borrowings | ||
| Short-term Borrowings | ||
| Trade Payables | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | ||
| Net Profit Margin | ||
| Return on Equity (ROE) | ||
| Return on Capital Employed (ROCE) | ||
| Return on Assets (ROA) | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Quick Ratio | ||
| Debt-to-Equity Ratio | ||
| Interest Coverage Ratio | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Payable Days | ||
| Inventory Days | ||
| Revenue Growth | ||
| Net Profit Growth | ||
To see the full financial statements and ratios of Maxcord Pharmaceuticals Private Limited, buy the company report.
Board of directors of Maxcord Pharmaceuticals Private Limited
Maxcord Pharmaceuticals has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Dhruv Bhatia Also directs: Supermax Laboratories Private Limited | Director | 15 Sep 2023 | 3 Years 1 Months | Current |
| Suresh Kumar Bhatia Also directs: Supermax Laboratories Private Limited | Director | 15 Sep 2023 | 3 Years 1 Months | Current |
| Kunal Bhatia Also directs: Supermax Laboratories Private Limited | Director | 15 Sep 2023 | 3 Years 1 Months | Current |
Legal cases
No court or tribunal cases involving Maxcord Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Maxcord Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Maxcord Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Maxcord Pharmaceuticals Private Limited has 3 board changes on record since 2023: 3 appointments. The latest: Dhruv Bhatia was appointed as Director on 15 Sep 2023.
Frequently asked questions
Maxcord Pharmaceuticals is an active private limited company based in Delhi, India. The company works in paper and paper products, within the paper industry. It was incorporated on 15 September 2023 (3+ years old) and is registered under CIN U21002DL2023PTC420088.
Maxcord Pharmaceuticals has 3 current directors:
- Dhruv Bhatia - Director
- Suresh Kumar Bhatia - Director
- Kunal Bhatia - Director
The latest financial statements of Maxcord Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2024 are in the company report.
The CIN (Corporate Identification Number) of Maxcord Pharmaceuticals is U21002DL2023PTC420088. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Maxcord Pharmaceuticals was incorporated on 15 September 2023, making it 3+ years old. It is registered with the Registrar of Companies, Delhi.
Dhruv Bhatia was appointed as Director on 15 Sep 2023. Kunal Bhatia was appointed as Director on 15 Sep 2023. Suresh Kumar Bhatia was appointed as Director on 15 Sep 2023.
The registered office of Maxcord Pharmaceuticals is at S N – 1705 GF, Bhagirath Palace, Delhi, India – 110006.
Maxcord Pharmaceuticals operates in the paper industry, in the paper and paper products segment.
Maxcord Pharmaceuticals can be reached at its registered office: S N – 1705 GF, Bhagirath Palace, Delhi, India – 110006.
Maxcord Pharmaceuticals is registered under the jurisdiction of the Registrar of Companies (ROC), Delhi.